haha also that study you’ve just snipped was a rat study on TBI and this is how they measured functional outcome. Gimme a spell! You surely don’t have a pharmacology degree?
- Forums
- ASX - By Stock
- Ann: Positive DSMB Safety Outcome & Phase 2 Trial Progress Update
haha also that study you’ve just snipped was a rat study on TBI...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
75.0¢ |
Change
-0.020(2.60%) |
Mkt cap ! $96.06M |
Open | High | Low | Value | Volume |
77.0¢ | 77.0¢ | 75.0¢ | $78.71K | 104.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7000 | 74.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
77.0¢ | 9781 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7000 | 0.745 |
1 | 10000 | 0.740 |
2 | 18626 | 0.735 |
1 | 40000 | 0.730 |
1 | 2798 | 0.715 |
Price($) | Vol. | No. |
---|---|---|
0.770 | 9781 | 1 |
0.790 | 7800 | 1 |
0.800 | 46089 | 1 |
0.830 | 10000 | 1 |
0.840 | 9000 | 1 |
Last trade - 15.25pm 13/11/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online